FDA inspection
Damien Sanderlin, MD: FDA inspection ending Mar 29, 2012
FDA inspection 775234 · Official Action Indicated (OAI) · Houston, TX
Key facts
| Inspection ID | 775234 |
|---|---|
| Firm | Damien Sanderlin, MD |
| FEI number | 3009417634 |
| Address | Lone Star Clinical Research, 8240 Antoine Dr Ste 107 |
| City | Houston |
| State | TX |
| ZIP | 77088 |
| Country | United States |
| Fiscal year | 2012 |
| Inspection end date | Mar 29, 2012 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data